Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Genetic Defects in Thyroid Hormone Supply.

Nettore IC, Fenzi G, Macchia PE.

In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, Korbonits M, McLachlan R, Morley JE, New M, Perreault L, Purnell J, Rebar R, Singer F, Trence DL, Vinik A, Wilson DP, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2018 Jan 12.

2.

Testing the saprobity hypothesis in a Mediterranean lagoon: effects of confinement and organic enrichment on benthic communities.

Foti A, Fenzi GA, Di Pippo F, Gravina MF, Magni P.

Mar Environ Res. 2014 Aug;99:85-94. doi: 10.1016/j.marenvres.2014.04.004. Epub 2014 May 2.

PMID:
24838081
3.

Identification and functional characterization of a novel mutation in the NKX2-1 gene: comparison with the data in the literature.

Nettore IC, Mirra P, Ferrara AM, Sibilio A, Pagliara V, Kay CS, Lorenzoni PJ, Werneck LC, Bruck I, Dos Santos LH, Beguinot F, Salvatore D, Ungaro P, Fenzi G, Scola RH, Macchia PE.

Thyroid. 2013 Jun;23(6):675-82. doi: 10.1089/thy.2012.0267.

PMID:
23379327
4.

β-Catenin regulates deiodinase levels and thyroid hormone signaling in colon cancer cells.

Dentice M, Luongo C, Ambrosio R, Sibilio A, Casillo A, Iaccarino A, Troncone G, Fenzi G, Larsen PR, Salvatore D.

Gastroenterology. 2012 Oct;143(4):1037-47. doi: 10.1053/j.gastro.2012.06.042. Epub 2012 Jul 3.

PMID:
22771508
5.

The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma.

Guerra A, Sapio MR, Marotta V, Campanile E, Rossi S, Forno I, Fugazzola L, Budillon A, Moccia T, Fenzi G, Vitale M.

J Clin Endocrinol Metab. 2012 Feb;97(2):517-24. doi: 10.1210/jc.2011-0618. Epub 2011 Dec 14.

PMID:
22170714
6.

High growth rate of benign thyroid nodules bearing RET/PTC rearrangements.

Sapio MR, Guerra A, Marotta V, Campanile E, Formisano R, Deandrea M, Motta M, Limone PP, Fenzi G, Rossi G, Vitale M.

J Clin Endocrinol Metab. 2011 Jun;96(6):E916-9. doi: 10.1210/jc.2010-1599. Epub 2011 Mar 16.

PMID:
21411555
7.

Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application.

Guerra A, Sapio MR, Marotta V, Campanile E, Moretti MI, Deandrea M, Motta M, Limone PP, Fenzi G, Rossi G, Vitale M.

Endocr J. 2011;58(1):31-8. Epub 2010 Dec 14.

8.

Screening for mutations in the ISL1 gene in patients with thyroid dysgenesis.

Ferrara AM, Rossi G, Zampella E, Di Candia S, Pagliara V, Nettore IC, Capalbo D, De Sanctis L, Baserga M, Salerno MC, Fenzi G, Macchia PE.

J Endocrinol Invest. 2011 Jul-Aug;34(7):e149-52. doi: 10.3275/7331. Epub 2010 Nov 8.

PMID:
21060249
9.

Growing thyroid nodules with benign histology and RET rearrangement.

Marotta V, Guerra A, Sapio MR, Campanile E, Motta M, Fenzi G, Rossi G, Vitale M.

Endocr J. 2010;57(12):1081-7. Epub 2010 Oct 30.

10.

The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration.

Dentice M, Marsili A, Ambrosio R, Guardiola O, Sibilio A, Paik JH, Minchiotti G, DePinho RA, Fenzi G, Larsen PR, Salvatore D.

J Clin Invest. 2010 Nov;120(11):4021-30. doi: 10.1172/JCI43670. Epub 2010 Oct 11.

11.

Are RET/PTC rearrangements in benign thyroid nodules of biological significance?

Marotta V, Guerra A, Sapio MR, Campanile E, Motta M, Fenzi G, Rossi G, Vitale M.

Thyroid. 2010 Oct;20(10):1191-2. doi: 10.1089/thy.2010.0061. No abstract available.

PMID:
20860421
12.

The Ca2+-calmodulin-dependent kinase II is activated in papillary thyroid carcinoma (PTC) and mediates cell proliferation stimulated by RET/PTC.

Rusciano MR, Salzano M, Monaco S, Sapio MR, Illario M, De Falco V, Santoro M, Campiglia P, Pastore L, Fenzi G, Rossi G, Vitale M.

Endocr Relat Cancer. 2010 Jan 29;17(1):113-23. doi: 10.1677/ERC-09-0214. Print 2010 Mar.

PMID:
19903742
13.

Mutations in TAZ/WWTR1, a co-activator of NKX2.1 and PAX8 are not a frequent cause of thyroid dysgenesis.

Ferrara AM, De Sanctis L, Rossi G, Capuano S, Del Prete G, Zampella E, Gianino P, Corrias A, Fenzi G, Zannini M, Macchia PE.

J Endocrinol Invest. 2009 Mar;32(3):238-41.

PMID:
19542741
14.

Insulin stimulates fibroblast proliferation through calcium-calmodulin-dependent kinase II.

Monaco S, Illario M, Rusciano MR, Gragnaniello G, Di Spigna G, Leggiero E, Pastore L, Fenzi G, Rossi G, Vitale M.

Cell Cycle. 2009 Jul 1;8(13):2024-30. Epub 2009 Jul 21.

PMID:
19502797
15.

Calcium-calmodulin-dependent kinase II (CaMKII) mediates insulin-stimulated proliferation and glucose uptake.

Illario M, Monaco S, Cavallo AL, Esposito I, Formisano P, D'Andrea L, Cipolletta E, Trimarco B, Fenzi G, Rossi G, Vitale M.

Cell Signal. 2009 May;21(5):786-92. doi: 10.1016/j.cellsig.2009.01.022. Epub 2009 Jan 9.

PMID:
19171190
16.

A novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea.

Ferrara AM, De Michele G, Salvatore E, Di Maio L, Zampella E, Capuano S, Del Prete G, Rossi G, Fenzi G, Filla A, Macchia PE.

Thyroid. 2008 Sep;18(9):1005-9. doi: 10.1089/thy.2008.0085.

PMID:
18788921
17.

Sediment features, macrozoobenthic assemblages and trophic relationships (delta13C and delta15N analysis) following a dystrophic event with anoxia and sulphide development in the Santa Giusta lagoon (western Sardinia, Italy).

Magni P, Rajagopal S, van der Velde G, Fenzi G, Kassenberg J, Vizzini S, Mazzola A, Giordani G.

Mar Pollut Bull. 2008;57(1-5):125-36. Epub 2008 Feb 21.

PMID:
18093619
18.

Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma.

Sapio MR, Guerra A, Posca D, Limone PP, Deandrea M, Motta M, Troncone G, Caleo A, Vallefuoco P, Rossi G, Fenzi G, Vitale M.

Endocr Relat Cancer. 2007 Dec;14(4):1089-97.

PMID:
18045960
19.

Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes.

Dentice M, Luongo C, Huang S, Ambrosio R, Elefante A, Mirebeau-Prunier D, Zavacki AM, Fenzi G, Grachtchouk M, Hutchin M, Dlugosz AA, Bianco AC, Missero C, Larsen PR, Salvatore D.

Proc Natl Acad Sci U S A. 2007 Sep 4;104(36):14466-71. Epub 2007 Aug 24.

20.

A new case of familial nonautoimmune hyperthyroidism caused by the M463V mutation in the TSH receptor with anticipation of the disease across generations: a possible role of iodine supplementation.

Ferrara AM, Capalbo D, Rossi G, Capuano S, Del Prete G, Esposito V, Montesano G, Zampella E, Fenzi G, Salerno M, Macchia PE.

Thyroid. 2007 Jul;17(7):677-80.

PMID:
17696839
21.

Detection of RET/PTC, TRK and BRAF mutations in preoperative diagnosis of thyroid nodules with indeterminate cytological findings.

Sapio MR, Posca D, Raggioli A, Guerra A, Marotta V, Deandrea M, Motta M, Limone PP, Troncone G, Caleo A, Rossi G, Fenzi G, Vitale M.

Clin Endocrinol (Oxf). 2007 May;66(5):678-83. Epub 2007 Mar 23.

PMID:
17381488
22.

Sediment characteristics and macrofauna distribution along a human-modified inlet in the Gulf of Oristano (Sardinia, Italy).

Como S, Magni P, Casu D, Floris A, Giordani G, Natale S, Fenzi GA, Signa G, De Falco G.

Mar Pollut Bull. 2007 Jun;54(6):733-44. Epub 2007 Mar 1.

PMID:
17335856
23.

Thyroid function and morphology after a successful kidney transplantation.

Tauchmanovà L, Carrano R, Musella T, Orio F, Sabbatini M, Lombardi G, Fenzi G, Federico S, Colao A.

J Endocrinol Invest. 2006 Jul-Aug;29(7):625-32.

PMID:
16957411
24.

Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?

Salvatore D, Fenzi G.

Nat Clin Pract Endocrinol Metab. 2006 Apr;2(4):194-5. No abstract available.

PMID:
16932282
25.

European Thyroid Association: 2006 in Naples.

Vecchio G, Fenzi G.

Thyroid. 2006 Aug;16(8):713-4. No abstract available.

PMID:
16910870
26.

Detection of BRAF mutation in thyroid papillary carcinomas by mutant allele-specific PCR amplification (MASA).

Sapio MR, Posca D, Troncone G, Pettinato G, Palombini L, Rossi G, Fenzi G, Vitale M.

Eur J Endocrinol. 2006 Feb;154(2):341-8.

PMID:
16452550
27.

Missense mutation in the transcription factor NKX2-5: a novel molecular event in the pathogenesis of thyroid dysgenesis.

Dentice M, Cordeddu V, Rosica A, Ferrara AM, Santarpia L, Salvatore D, Chiovato L, Perri A, Moschini L, Fazzini C, Olivieri A, Costa P, Stoppioni V, Baserga M, De Felice M, Sorcini M, Fenzi G, Di Lauro R, Tartaglia M, Macchia PE.

J Clin Endocrinol Metab. 2006 Apr;91(4):1428-33. Epub 2006 Jan 17.

PMID:
16418214
28.

Pendrin is a novel in vivo downstream target gene of the TTF-1/Nkx-2.1 homeodomain transcription factor in differentiated thyroid cells.

Dentice M, Luongo C, Elefante A, Ambrosio R, Salzano S, Zannini M, Nitsch R, Di Lauro R, Rossi G, Fenzi G, Salvatore D.

Mol Cell Biol. 2005 Nov;25(22):10171-82.

29.

Fibronectin-induced proliferation in thyroid cells is mediated by alphavbeta3 integrin through Ras/Raf-1/MEK/ERK and calcium/CaMKII signals.

Illario M, Cavallo AL, Monaco S, Di Vito E, Mueller F, Marzano LA, Troncone G, Fenzi G, Rossi G, Vitale M.

J Clin Endocrinol Metab. 2005 May;90(5):2865-73. Epub 2005 Feb 1.

PMID:
15687337
30.

Recombinant thyrotropin-induced orbital uptake of [111In-diethylenetriamine-pentacetic acid-D-Phe1]octreotide in a patient with inactive Graves' ophthalmopathy.

Savastano S, Pivonello R, Acampa W, Salvatore M, Lombardi G, Colao A, Fenzi G.

J Clin Endocrinol Metab. 2005 Apr;90(4):2440-4. Epub 2005 Feb 1.

PMID:
15687327
31.

Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells.

Dentice M, Luongo C, Elefante A, Romino R, Ambrosio R, Vitale M, Rossi G, Fenzi G, Salvatore D.

Mol Cell Biol. 2004 Sep;24(18):7863-77.

32.

Calcium/calmodulin-dependent protein kinase II binds to Raf-1 and modulates integrin-stimulated ERK activation.

Illario M, Cavallo AL, Bayer KU, Di Matola T, Fenzi G, Rossi G, Vitale M.

J Biol Chem. 2003 Nov 14;278(46):45101-8. Epub 2003 Sep 3.

33.
34.

Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.

Maio M, Coral S, Sigalotti L, Elisei R, Romei C, Rossi G, Cortini E, Colizzi F, Fenzi G, Altomonte M, Pinchera A, Vitale M.

J Clin Endocrinol Metab. 2003 Feb;88(2):748-54.

PMID:
12574209
35.

Integrin-dependent cell growth and survival are mediated by different signals in thyroid cells.

Illario M, Amideo V, Casamassima A, Andreucci M, di Matola T, Miele C, Rossi G, Fenzi G, Vitale M.

J Clin Endocrinol Metab. 2003 Jan;88(1):260-9.

PMID:
12519863
36.

Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer.

Biondi B, Palmieri EA, Pagano L, Klain M, Scherillo G, Salvatore M, Fenzi G, Lombardi G, Fazio S.

J Clin Endocrinol Metab. 2003 Jan;88(1):211-4.

PMID:
12519854
37.

Lovastatin-induced apoptosis in thyroid cells: involvement of cytochrome c and lamin B.

Di Matola T, D'Ascoli F, Luongo C, Bifulco M, Rossi G, Fenzi G, Vitale M.

Eur J Endocrinol. 2001 Nov;145(5):645-50.

PMID:
11720884
38.

Desethylamiodarone antagonizes the effect of thyroid hormone at the molecular level.

Bogazzi F, Bartalena L, Brogioni S, Burelli A, Raggi F, Ultimieri F, Cosci C, Vitale M, Fenzi G, Martino E.

Eur J Endocrinol. 2001 Jul;145(1):59-64.

PMID:
11415853
39.

High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy.

Macchia PE, Bagattini M, Lupoli G, Vitale M, Vitale G, Fenzi G.

J Endocrinol Invest. 2001 Mar;24(3):152-8.

PMID:
11314743
40.

Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.

Salvatore D, Melillo RM, Monaco C, Visconti R, Fenzi G, Vecchio G, Fusco A, Santoro M.

Cancer Res. 2001 Feb 15;61(4):1426-31.

41.

Amiodarone induces cytochrome c release and apoptosis through an iodine-independent mechanism.

Di Matola T, D'Ascoli F, Fenzi G, Rossi G, Martino E, Bogazzi F, Vitale M.

J Clin Endocrinol Metab. 2000 Nov;85(11):4323-30.

PMID:
11095475
42.

Clinical implications of somatostatin-receptor scintigraphy in ophthalmic Graves' disease.

Colao A, Pivonello R, Lastoria S, Faggiano A, Ferone D, Lombardi G, Fenzi G.

Eur J Endocrinol. 2000 Oct;143 Suppl 1:S35-42. Review. No abstract available.

PMID:
11068938
43.

Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins.

Salvatore D, Barone MV, Salvatore G, Melillo RM, Chiappetta G, Mineo A, Fenzi G, Vecchio G, Fusco A, Santoro M.

J Clin Endocrinol Metab. 2000 Oct;85(10):3898-907.

PMID:
11061555
44.

Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease.

Colao A, Pivonello R, Faggiano A, Filippella M, Ferone D, Di Somma C, Cerbone G, Marzullo P, Fenzi G, Lombardi G.

Clin Endocrinol (Oxf). 2000 Jul;53(1):13-9.

PMID:
10931076
45.

Serum withdrawal-induced apoptosis in thyroid cells is caused by loss of fibronectin-integrin interaction.

Di Matola T, Mueller F, Fenzi G, Rossi G, Bifulco M, Marzano LA, Vitale M.

J Clin Endocrinol Metab. 2000 Mar;85(3):1188-93.

PMID:
10720060
46.

Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress.

Vitale M, Di Matola T, D'Ascoli F, Salzano S, Bogazzi F, Fenzi G, Martino E, Rossi G.

Endocrinology. 2000 Feb;141(2):598-605.

PMID:
10650940
47.

Power Doppler improves the diagnostic accuracy of color Doppler ultrasonography in cold thyroid nodules: follow-up results.

Cerbone G, Spiezia S, Colao A, Di Sarno A, Assanti AP, Lucci R, Siciliani M, Lombardi G, Fenzi G.

Horm Res. 1999;52(1):19-24.

PMID:
10640895
48.

Percutaneous ethanol injection under Power Doppler ultrasound assistance in the treatment of autonomously functioning thyroid nodules.

Cerbone G, Spiezia S, Colao A, Marzullo P, Assanti AP, Lucci R, Zarrilli S, Siciliani M, Fenzi G, Lombardi G.

J Endocrinol Invest. 1999 Nov;22(10):752-9.

PMID:
10614524
49.
50.

Expression of integrins of the beta1 family in thyroid cells from patients with Graves' disease in vivo and in vitro.

Vitale M, De Riu S, Fenzi GF, Casamassima A, Salzano S, Müeller F, Marzano LA, Rossi G.

Biochimie. 1999 May;81(5):477-84.

PMID:
10403178

Supplemental Content

Support Center